The concept of schizophrenia;El concepto de esquizofrenia

Revista de Psiquiatria y Salud Mental

Volumn 2, Issue 3, 2009, Pages 105-107

  Kirkpatrick, Brian ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; NEUROLEPTIC AGENT;

BETA ADRENERGIC RECEPTOR BLOCKING; COGNITION; COMORBIDITY; DIABETES MELLITUS; EDITORIAL; HUMAN; HYPERTENSION; MORTALITY; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PREVALENCE; PSYCHOSIS; RISK FACTOR; SCHIZOPHRENIA;

EID: 71049192406     PISSN: 18889891     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1888-9891(09)72400-0     Document Type: Editorial

References (21)

1. M. Sodhi, K.H. Wood, and J. Meador-Woodruff Role of glutamate in schizophrenia: integrating excitatory avenues of research Expert Rev Neurother 8 2008 1389 1406
2. G. Remington Alterations of dopamine and serotonin transmission in schizophrenia Prog Brain Res 172 2008 117 140
3. P.F. Buckley, B. Miller, Douglas Lehrer, and D. Castle Psychiatric comorbidities and schizophrenia Schizophr Bull 35 2009 383 402
4. D. Dickinson, M.E. Ramsey, and J.M. Gold Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia Arch Gen Psychiatry 64 2007 532 542
5. M.F. Green Cognitive impairment and functional outcome in schizophrenia and bipolar disorder J Clin Psychiatry 67 Suppl 9 2006 3 8
6. P.F. Whitty, O. Owoeye, and J.L. Waddington Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology Schizophr Bull 35 2009 415 424
7. S.M. Weinberg, E.A. Jenkins, M.L. Marazita, and B.S. Maher Minor physical anomalies in schizophrenia: a meta-analysis Schizophr Res 89 2007 72 85
8. K. Wahlbeck, T. Forsén, C. Osmond, D.J. Barker, and J.G. Eriksson Association of schizophrenia with low maternal body mass index, small size at birth, and thinness during childhood Arch Gen Psychiatry 58 2001 48 52 (Pubitemid 32057764)
9. M.C. Ryan, P. Collins, and J.H. Thakore Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia Am J Psychiatry 160 2003 284 289
10. E. Fernandez-Egea, M. Bernardo, T. Donner, I. Conget, E. Parellada, A. Justicia, et al. The metabolic profile of antipsychoticnaïve patients with nonaffective psychosis Br J Psychiatry 194 2009 434 438
11. B. Crespo-Facorro, E. Carrasco-Marín, R. Pérez-Iglesias, J.M. Pelayo-Terán, L. Fernandez-Prieto, F. Leyva-Cobián, et al. Interleukin-12 plasma levels in drug-naïve patients with a first episode of psychosis: effects of antipsychotic drugs Psychiatry Res 158 2008 206 216
12. E. Fernandez-Egea, M. Bernardo, C.M. Heaphy, J.K. Griffith, E. Parellada, E. Esmatjes, et al. Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis Schizophr Bull 35 2009 437 442
13. M.H. Rapaport, and J.B. Lohr Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia Acta Psychiatr Scand 90 1994 311 315
14. D. Dickinson, J.M. Gold, F.B. Dickerson, D. Medoff, and L.B. Dixon Evidence of exacerbated cognitive deficits in schizophrenia patients with comorbid diabetes Psychosomatics 49 2008 123 131
15. S. Akhondzadeh, M. Tabatabaee, H. Amini, S.A. Ahmadi Abhari, S.H. Abbasi, and B. Behnam Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial Schizophr Res 90 2007 179 185 (Pubitemid 46177578)
16. N. Müller, M. Ulmschneider, C. Scheppach, M.J. Schwarz, M. Ackenheil, H.J. Möller, et al. COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy Eur Arch Psychiatry Clin Neurosci 254 2004 14 22
17. Fernandez-Egea E, Bruna A, Garcia-Rizo C, Bernardo M, Kirkpatrick B. Stem cell signaling in newly diagnosed, antipsychotic-naïve subjects with nonaffective psychosis. Mol Psychiatry. 2009 [en prensa].
18. E. Fernandez-Egea, M. Bernardo, E. Parellada, A. Justicia, C. Garcia-Rizo, E. Esmatjes, et al. Glucose abnormalities in the siblings of people with schizophrenia Schizophr Res 103 2008 110 113
19. E. Fernandez-Egea, B. Miller, M. Bernardo, T. Donner, and B. Kirkpatrick Parental history of type 2 diabetes in patients with nonaffective psychosis Schizophr Res 98 2008 302 306
20. L.M. Spelman, P.I. Walsh, N. Sharifi, P. Collins, and J.H. Thakore Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia Diabet Med 24 2007 481 485
21. S. Saha, D. Chant, and J. McGrath A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 64 2007 1123 1131